018858680	018858680	CD	B-NP	O
|	|	NN	I-NP	O
AOH	AOH	NN	I-NP	O
|	|	NN	I-NP	O
80239131	80239131	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9725704	9725704	CD	B-NP	O
|	|	CC	I-NP	O
11/4/2005	11/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/7/2005	5/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/8/2005	10/8/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SATOW	SATOW	NNP	B-NP	O
,	,	,	O	O
DARNELL	DARNELL	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Schmittou	Schmittou	NNP	I-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
she	she	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
Demadex	Demadex	NN	I-NP	O
from	from	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
174	174	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
noticed	notice	VBD	B-VP	O
worsening	worsen	VBG	B-NP	O
of	of	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
PND	PND	NN	B-NP	O
or	or	CC	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
bloating	bloat	VBG	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
satiety	satiety	NN	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
discomfort	discomfort	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	I-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
occasional	occasional	JJ	B-NP	O
chest	chest	NN	I-NP	O
burning	burning	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
burning	burn	VBG	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
bilaterally	bilaterally	RB	B-PP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
neuropathy	neuropathy	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Outpatient	Outpatient	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	I-NP	O
repeat	repeat	NN	I-NP	O
exercise	exercise	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
uptake	uptake	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
32	32	CD	B-NP	O
seconds	second	NNS	I-NP	O
achieving	achieve	VBG	B-VP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
100/64	100/64	CD	B-NP	O
and	and	CC	O	O
stopping	stop	VBG	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
uptake	uptake	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
9	9	CD	I-NP	O
mL	mL	NN	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
despite	despite	IN	B-PP	O
on	on	IN	B-PP	O
RER	RER	NN	B-NP	O
of	of	IN	B-PP	O
1.09	1.09	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypertriglyceridemia	hypertriglyceridemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
bundle-branch	bundle-branch	NN	B-NP	O
block	block	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
ICD	ICD	NN	I-NP	O
and	and	CC	O	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pacer	pacer	NN	I-NP	O
is	be	VBZ	B-VP	O
biventricular	biventricular	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
hysteroscopy	hysteroscopy	NN	I-NP	O
and	and	CC	I-NP	O
laparoscopy	laparoscopy	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Demadex	Demadex	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Aldactone	Aldactone	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
Evista	Evista	JJ	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
104/66	104/66	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
174	174	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
16	16	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
with	with	IN	B-PP	O
hepatojugular	hepatojugular	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
angle	angle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
carotid	carotid	NN	I-NP	O
upstrokes	upstroke	NNS	I-NP	O
were	be	VBD	B-VP	O
brisk	brisk	JJ	B-ADJP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
in	in	IN	B-PP	O
rate	rate	NN	B-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
audible	audible	JJ	B-NP	O
S3	S3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
liver	liver	NN	B-NP	O
edge	edge	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
palpable	palpable	JJ	B-ADJP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
fingerbreadths	fingerbreadth	NNS	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
noncyanotic	noncyanotic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
lukewarm	lukewarm	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Unremarkable	Unremarkable	JJ	B-ADJP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
labs	lab	NNS	I-NP	O
had	have	VBD	B-VP	O
showed	show	VBN	I-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
138	138	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
3.9	3.9	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
67	67	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
123	123	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
all	all	DT	O	O
normal	normal	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
lipids	lipid	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
of	of	IN	B-PP	O
128	128	CD	B-NP	O
with	with	IN	B-PP	O
191	191	CD	B-NP	O
triglycerides	triglyceride	NNS	I-NP	O
and	and	CC	I-NP	O
HDL	HDL	NN	I-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
LDL	LDL	NN	I-NP	B-protein
of	of	IN	B-PP	O
59	59	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
CBC	CBC	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
a-sensed	a-sensed	JJ	I-NP	O
V-paced	V-paced	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Helger	Helger	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
class	class	NN	I-NP	O
II-III	II-III	CD	B-NP	O
symptoms	symptom	NNS	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
already	already	RB	I-VP	O
maximized	maximize	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
diuretic	diuretic	JJ	I-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
somewhat	somewhat	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
torsemide	torsemide	NN	I-NP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	O	O
switched	switch	VBD	B-VP	O
over	over	RP	B-PRT	O
from	from	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
captopril	captopril	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
hypotensive	hypotensive	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
go	go	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
increased	increase	VBN	B-NP	O
RA	RA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
35-44	35-44	CD	B-NP	O
with	with	IN	B-PP	O
V	V	NN	B-NP	O
wave	wave	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
at	at	IN	B-PP	O
1.38	1.38	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
at	at	IN	B-PP	O
1600	1600	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mixed	mixed	JJ	I-NP	O
venous	venous	JJ	I-NP	O
O2	O2	NN	I-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
between	between	IN	B-PP	O
52	52	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
readings	reading	NNS	I-NP	O
were	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
Lasix	Lasix	NN	B-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
to	to	TO	I-VP	O
accelerate	accelerate	VB	I-VP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
tailored	tailor	VBN	B-NP	O
therapy	therapy	NN	I-NP	O
including	include	VBG	B-PP	O
nitrates	nitrate	NNS	B-NP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
up	up	RP	I-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
captopril	captopril	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
impressive	impressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
workup	workup	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
included	include	VBD	B-VP	O
PFTs	PFT	NNS	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
2.64	2.64	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
his	his	PRP$	B-NP	O
86	86	CD	I-NP	O
%	%	NN	I-NP	O
predicted	predict	VBD	B-VP	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
1.82	1.82	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBN	B-VP	O
and	and	CC	O	O
FEV1	FEV1	NN	B-NP	O
to	to	TO	B-PP	O
FVC	FVC	NN	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
69	69	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
corrected	correct	VBN	I-NP	O
DLCO	DLCO	NNP	I-NP	O
was	be	VBD	B-VP	O
14.6	14.6	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
56	56	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
a	a	DT	B-NP	O
carotid	carotid	JJ	I-NP	O
duplex	duplex	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showing	show	VBG	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
either	either	CC	B-NP	O
carotid	carotid	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ankle	ankle	JJ	I-NP	O
brachial	brachial	JJ	I-NP	O
indices	index	NNS	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
leg	leg	NN	I-NP	O
pulse	pulse	NN	I-NP	O
volume	volume	NN	I-NP	O
recording	recording	NN	I-NP	O
was	be	VBD	B-VP	O
all	all	RB	B-ADJP	O
entirely	entirely	RB	I-ADJP	O
normal	normal	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
920	920	CD	B-NP	O
mg	mg	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
volume	volume	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
continued	continue	VBD	I-VP	O
to	to	TO	I-VP	O
respond	respond	VB	I-VP	O
reasonable	reasonable	JJ	B-ADJP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
did	do	VBD	B-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
bump	bump	VB	I-VP	O
marginally	marginally	RB	B-VP	O
indicating	indicate	VBG	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
likely	likely	RB	I-VP	O
been	be	VBN	I-VP	O
slightly	slightly	RB	B-ADVP	O
over	over	IN	B-PP	O
diuresed	diuresed	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
stabilized	stabilize	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
including	include	VBG	B-PP	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
other	other	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
captopril	captopril	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Claritin	Claritin	NNP	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
thiamine	thiamine	NN	I-NP	O
and	and	CC	I-NP	O
multivitamin	multivitamin	NN	I-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
,	,	,	O	O
Evista	Evista	NNP	B-NP	O
,	,	,	I-NP	O
Aldactone	Aldactone	NNP	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
plan	plan	NN	B-NP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-0881993	6-0881993	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
TARWATER	TARWATER	NN	B-NP	O
,	,	,	O	O
CHARLIE	CHARLIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JECMENEK	JECMENEK	NNP	B-NP	O
,	,	,	O	O
STUART	STUART	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7477204	7477204	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/7/05	7/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/7/05	7/7/05	CD	B-NP	O

